Hyderabad Telangana, India

Padmavathi Kodru

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suven Life Sciences Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Padmavathi Kodru. Retrieved from https://idiyas.com/inventor/padmavathi-kodru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Padmavathi Kodru: Innovator in Pharmaceutical Compounds

Introduction

Padmavathi Kodru is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclyl compounds. His work focuses on creating compounds that can be used in the treatment of various disorders.

Latest Patents

Padmavathi holds 1 patent related to heterocyclyl compounds of formula (I) and their pharmaceutically acceptable salts and compositions. This invention also includes a process for the preparation of these novel compounds. The compounds are particularly useful in treating disorders associated with Histamine H receptors, including cognitive disorders, sleep disorders, obesity, and pain.

Career Highlights

He is currently employed at Suven Life Sciences Limited, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the field has positioned him as a valuable asset to his company.

Collaborations

Padmavathi has collaborated with notable colleagues such as Ramakrishna Nirogi and Anil Karbhari Shinde, enhancing the research and development efforts at Suven Life Sciences Limited.

Conclusion

Padmavathi Kodru's work in pharmaceutical innovations demonstrates his commitment to improving health outcomes through scientific advancements. His contributions are paving the way for new treatments that address significant health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…